ASTRAZENECA PLC Form 6-K: Report of foreign private issuer
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2025-01-28: Form 6-K; Period of report 2025-01-28; Description ENHERTU APPROVED IN US FOR BREAST CANCER POST ET; Document a9335u.htm.
- 2025-01-21: Form 6-K; Period of report 2025-01-21; Description DATO-DXD APPROVED IN US FOR HR+ BREAST CANCER; Document a8555t.htm.
- 2025-01-17: Form 6-K; Period of report 2025-01-17; Description CALQUENCE COMBINATION APPROVED IN US FOR 1L MCL; Document a7490t.htm.
- 2025-01-02: Form 6-K; Period of report 2025-01-02; Description TOTAL VOTING RIGHTS; Document a9281r.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2025-01-28 | 6-K | 2025-01-28 | ENHERTU APPROVED IN US FOR BREAST CANCER POST ET | a9335u.htm |
| 2025-01-21 | 6-K | 2025-01-21 | DATO-DXD APPROVED IN US FOR HR+ BREAST CANCER | a8555t.htm |
| 2025-01-17 | 6-K | 2025-01-17 | CALQUENCE COMBINATION APPROVED IN US FOR 1L MCL | a7490t.htm |
| 2025-01-02 | 6-K | 2025-01-02 | TOTAL VOTING RIGHTS | a9281r.htm |